Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Link to relevant study record(s)

Description of key information

Following a conservative approach, 10% absorption via oral, dermal and inhalative route are assumed, althoug true absorption is expected an order of magnitude lower. Potential for bioaccumulation is not expected.

Key value for chemical safety assessment

Bioaccumulation potential:
no bioaccumulation potential
Absorption rate - oral (%):
Absorption rate - dermal (%):
Absorption rate - inhalation (%):

Additional information

Aradur 460 J 90 BD is expected to have very limited absorption into body via oral and dermal route (anticipated <1%). Inhalation exposure is not a foreseeable route due to the physico-chemical properties (i.e., low vapor pressure, high molecular weight, not highly soluble in water, highly viscous liquid). Based on the poor absorption, it can be expected that Aradur 460 J 90 BD has very low bioavailability, and systemic distribution is not relevant. Therefore, Aradur 460 J 90 BD is expected to be excreted unchanged in the faeces and urine, and will not bioaccumulate in the body.Any uptake portion is estimated to be excreted in the form of glucuronide conjugate.